Related Experiment Video
Updated: May 20, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
The possible role of the Akt signaling pathway in schizophrenia
Wenhua Zheng1, Haitao Wang, Zhiwen Zeng
1Neuropharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. whzheng123@gmail.com
Abstract:
Serine/threonine protein kinase v-akt murine thymoma viral oncogene homolog (Akt) is one of the survival kinases with multiple biological functions in the brain and throughout the body. Schizophrenia is one of the most devastating psychiatric disorders. Accumulating evidence has indicated the involvement of the Akt signaling pathway in the pathogenesis of this disorder. Genetic linkage and association studies have identified Akt-1 as a candidate susceptibility gene related for schizophrenia. The level of Akt-1 protein and its kinase activity decreased significantly both in white blood cells from schizophrenic patients and in postmortem brain tissue of schizophrenic patients. Consistent with these findings, alterations in the upstream and downstream pathways of Akt have also been found in many psychiatric disorders. Furthermore, both typical and atypical antipsychotic drugs modify the Akt signaling pathway in a variety of conditions relative to schizophrenia. In addition as a survival kinase, Akt participates in neurodevelopment, synaptic plasticity, protein synthesis and neurotransmission in the central nervous system. It is thought that reduced activity of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway could at least partially explain the cognitive impairment, synaptic morphologic abnormality, neuronal atrophy and dysfunction of neurotransmitter signaling in schizophrenia. In addition, reduced levels of Akt may increase the effects of risk factors on neurodevelopment, attenuate the effects of growth factors on neurodevelopment and reduce the response of patients to antipsychotic agents. More recently, the role of Akt signaling in the functions of schizophrenia susceptibility genes such as disrupted-in-schizophrenia 1 (DISC-1), neuregulin-1 (NRG-1) and dysbindin-1 has been reported. Thus, Akt deficiency may create a context permissive for the expression of risk-gene effects in neuronal morphology and function. This paper reviews the role of Akt in the pathophysiology of schizophrenia and as a potential therapeutic strategy targeting Akt.
Insights
Reduced activity of the Akt signaling pathway is implicated in schizophrenia, affecting cognitive function and neuronal health. Targeting Akt may offer a novel therapeutic strategy for this devastating psychiatric disorder.
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- Schizophrenia is a severe psychiatric disorder with complex pathophysiology.
- The Akt signaling pathway, a key regulator of cell survival and function, is increasingly implicated in brain disorders.
- Evidence suggests Akt pathway dysregulation contributes to schizophrenia's development and progression.
Purpose of the Study:
- To review the role of the Akt signaling pathway in the pathophysiology of schizophrenia.
- To explore Akt as a potential therapeutic target for schizophrenia treatment.
Main Methods:
- Review of genetic linkage and association studies identifying Akt-1 as a schizophrenia susceptibility gene.
- Analysis of studies examining Akt-1 protein levels and kinase activity in patients.
- Examination of research on upstream and downstream Akt pathway alterations in psychiatric disorders.
- Investigation of antipsychotic drug effects on the Akt pathway.
- Review of Akt's role in neurodevelopment, synaptic plasticity, and neurotransmission.
Main Results:
- Akt-1 is a candidate gene for schizophrenia.
- Significantly decreased Akt-1 protein levels and kinase activity observed in schizophrenic patients.
- Alterations in Akt signaling pathways are found in various psychiatric disorders.
- Antipsychotic drugs modulate the Akt signaling pathway.
- Reduced PI3K/Akt signaling may underlie cognitive impairment and neuronal abnormalities in schizophrenia.
Conclusions:
- Akt signaling pathway plays a crucial role in schizophrenia pathophysiology.
- Akt deficiency may exacerbate the effects of genetic risk factors and reduce treatment response.
- Targeting the Akt pathway presents a promising therapeutic strategy for schizophrenia.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...